04/04/2005
Federal Register Final rule: FDA is amending its regulation on the use of ozone-depleting substances in self-pressurized container...04/01/2005
Federal Register Notice: FDA is making available a guidance entitled E2E Pharmacovigilance Planning. The guidance was prepared und...04/01/2005
Federal Register Notice: FDA submitted a proposed collection of information entitled “Medical Device Labeling Regulations &#...03/30/2005
Federal Register Notice: FDA is making available three guidances for industry entitled Premarketing Risk Assessment, Development a...03/30/2005
Federal Register Notice: FDA’s proposed collection of information, “Format and Content for Over-the-Counter (OTC) Drug...03/30/2005
Federal Register Notice: FDA is referring Kemstro (baclofen) and Droxia (hydroxyurea) to the Foundation for the National Institute...03/30/2005
Federal Register Notice: FDA makes available a draft guidance entitled Systemic Lupus Erythematosus — Developing Drugs for T...03/30/2005
Federal Register Notice: FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet 6/6, from 8 a.m. to 5:30 p.m. at the CDE...